nodes	percent_of_prediction	percent_of_DWPC	metapath
Folic Acid—Methotrexate—colon cancer	0.413	1	CrCtD
Folic Acid—GGH—Methotrexate—colon cancer	0.0675	0.24	CbGbCtD
Folic Acid—Pralatrexate—Methotrexate—colon cancer	0.0547	0.2	CrCrCtD
Folic Acid—Pemetrexed—Methotrexate—colon cancer	0.0547	0.2	CrCrCtD
Folic Acid—Raltitrexed—Methotrexate—colon cancer	0.0547	0.2	CrCrCtD
Folic Acid—Leucovorin—Methotrexate—colon cancer	0.0547	0.2	CrCrCtD
Folic Acid—Tetrahydrofolic acid—Methotrexate—colon cancer	0.0547	0.2	CrCrCtD
Folic Acid—SLC46A1—Methotrexate—colon cancer	0.0388	0.138	CbGbCtD
Folic Acid—MTHFR—Fluorouracil—colon cancer	0.0367	0.131	CbGbCtD
Folic Acid—ABCC11—Methotrexate—colon cancer	0.0324	0.115	CbGbCtD
Folic Acid—MTHFR—Methotrexate—colon cancer	0.0203	0.072	CbGbCtD
Folic Acid—ABCC3—Fluorouracil—colon cancer	0.0162	0.0577	CbGbCtD
Folic Acid—ABCC3—Vincristine—colon cancer	0.0148	0.0526	CbGbCtD
Folic Acid—ABCC4—Fluorouracil—colon cancer	0.0124	0.0441	CbGbCtD
Folic Acid—ABCC3—Methotrexate—colon cancer	0.00895	0.0318	CbGbCtD
Folic Acid—ABCG2—Irinotecan—colon cancer	0.00695	0.0247	CbGbCtD
Folic Acid—ABCC4—Methotrexate—colon cancer	0.00684	0.0243	CbGbCtD
Folic Acid—ABCG2—Fluorouracil—colon cancer	0.00667	0.0237	CbGbCtD
Folic Acid—ABCG2—Vincristine—colon cancer	0.00607	0.0216	CbGbCtD
Folic Acid—ABCG2—Methotrexate—colon cancer	0.00368	0.0131	CbGbCtD
Folic Acid—SLC22A6—Methotrexate—colon cancer	0.00298	0.0106	CbGbCtD
Folic Acid—ABCC11—embryo—colon cancer	0.00128	0.0653	CbGeAlD
Folic Acid—FOLR3—bone marrow—colon cancer	0.00118	0.0605	CbGeAlD
Folic Acid—GGH—Fluoropyrimidine Activity—TYMS—colon cancer	0.000945	0.0986	CbGpPWpGaD
Folic Acid—MTHFR—blood vessel—colon cancer	0.000937	0.048	CbGeAlD
Folic Acid—SLC25A32—smooth muscle tissue—colon cancer	0.00091	0.0466	CbGeAlD
Folic Acid—GGH—smooth muscle tissue—colon cancer	0.000695	0.0356	CbGeAlD
Folic Acid—GGH—renal system—colon cancer	0.000669	0.0343	CbGeAlD
Folic Acid—SLC25A32—bone marrow—colon cancer	0.000662	0.0339	CbGeAlD
Folic Acid—ABCC3—gall bladder—colon cancer	0.00066	0.0338	CbGeAlD
Folic Acid—FOLR2—bone marrow—colon cancer	0.000657	0.0337	CbGeAlD
Folic Acid—SLC25A32—vagina—colon cancer	0.000635	0.0325	CbGeAlD
Folic Acid—FOLR2—vagina—colon cancer	0.00063	0.0322	CbGeAlD
Folic Acid—Raltitrexed—TYMS—colon cancer	0.000627	0.283	CrCbGaD
Folic Acid—ABCC11—liver—colon cancer	0.00059	0.0302	CbGeAlD
Folic Acid—SLC46A1—lymphoid tissue—colon cancer	0.000565	0.0289	CbGeAlD
Folic Acid—SLC46A1—digestive system—colon cancer	0.000558	0.0286	CbGeAlD
Folic Acid—GGH—digestive system—colon cancer	0.000549	0.0281	CbGeAlD
Folic Acid—SLC25A32—liver—colon cancer	0.000535	0.0274	CbGeAlD
Folic Acid—FOLR2—liver—colon cancer	0.000531	0.0272	CbGeAlD
Folic Acid—GGH—bone marrow—colon cancer	0.000506	0.0259	CbGeAlD
Folic Acid—GGH—vagina—colon cancer	0.000485	0.0248	CbGeAlD
Folic Acid—Pralatrexate—TYMS—colon cancer	0.000475	0.214	CrCbGaD
Folic Acid—Leucovorin—TYMS—colon cancer	0.000475	0.214	CrCbGaD
Folic Acid—ABCC11—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000472	0.0492	CbGpPWpGaD
Folic Acid—SLC46A1—liver—colon cancer	0.000416	0.0213	CbGeAlD
Folic Acid—SLC25A32—lymph node—colon cancer	0.00041	0.021	CbGeAlD
Folic Acid—GGH—liver—colon cancer	0.000409	0.0209	CbGeAlD
Folic Acid—FOLR2—lymph node—colon cancer	0.000407	0.0209	CbGeAlD
Folic Acid—ABCG2—Abacavir transmembrane transport—ABCB1—colon cancer	0.000405	0.0422	CbGpPWpGaD
Folic Acid—ABCC3—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000403	0.042	CbGpPWpGaD
Folic Acid—Pemetrexed—TYMS—colon cancer	0.00038	0.171	CrCbGaD
Folic Acid—MTHFR—lymphoid tissue—colon cancer	0.000351	0.018	CbGeAlD
Folic Acid—MTHFR—digestive system—colon cancer	0.000347	0.0178	CbGeAlD
Folic Acid—SLC46A1—lymph node—colon cancer	0.000319	0.0163	CbGeAlD
Folic Acid—ABCC3—renal system—colon cancer	0.000317	0.0162	CbGeAlD
Folic Acid—GGH—lymph node—colon cancer	0.000314	0.0161	CbGeAlD
Folic Acid—GGH—Fluoropyrimidine Activity—TP53—colon cancer	0.000313	0.0327	CbGpPWpGaD
Folic Acid—ABCC4—renal system—colon cancer	0.000261	0.0134	CbGeAlD
Folic Acid—ABCC3—digestive system—colon cancer	0.00026	0.0133	CbGeAlD
Folic Acid—MTHFR—liver—colon cancer	0.000258	0.0132	CbGeAlD
Folic Acid—FOLR2—Folate Metabolism—TP53—colon cancer	0.000238	0.0248	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—TP53—colon cancer	0.000238	0.0248	CbGpPWpGaD
Folic Acid—ABCG2—Abacavir transport and metabolism—ABCB1—colon cancer	0.000232	0.0242	CbGpPWpGaD
Folic Acid—MTHFR—One Carbon Metabolism—TYMS—colon cancer	0.000226	0.0236	CbGpPWpGaD
Folic Acid—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.00022	0.023	CbGpPWpGaD
Folic Acid—ABCC4—digestive system—colon cancer	0.000214	0.011	CbGeAlD
Folic Acid—Methotrexate—TYMS—colon cancer	0.00021	0.0944	CrCbGaD
Folic Acid—SLC25A32—Metabolism—CA7—colon cancer	0.000208	0.0217	CbGpPWpGaD
Folic Acid—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000207	0.0216	CbGpPWpGaD
Folic Acid—MTHFR—Trans-sulfuration and one carbon metabolism—TYMS—colon cancer	0.000203	0.0212	CbGpPWpGaD
Folic Acid—MTHFR—Fluoropyrimidine Activity—TYMS—colon cancer	0.000198	0.0207	CbGpPWpGaD
Folic Acid—MTHFR—lymph node—colon cancer	0.000198	0.0101	CbGeAlD
Folic Acid—ABCC4—bone marrow—colon cancer	0.000198	0.0101	CbGeAlD
Folic Acid—ABCC3—liver—colon cancer	0.000193	0.00991	CbGeAlD
Folic Acid—SLC25A32—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	0.000184	0.0192	CbGpPWpGaD
Folic Acid—CYP2E1—renal system—colon cancer	0.00016	0.00818	CbGeAlD
Folic Acid—ABCC4—liver—colon cancer	0.00016	0.00818	CbGeAlD
Folic Acid—SLC25A32—Disease—CHST5—colon cancer	0.00015	0.0157	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—LGR5—colon cancer	0.00015	0.0157	CbGpPWpGaD
Folic Acid—ABCC3—lymph node—colon cancer	0.000148	0.0076	CbGeAlD
Folic Acid—ABCG2—bone marrow—colon cancer	0.000139	0.00714	CbGeAlD
Folic Acid—CYP2E1—Metapathway biotransformation—CHST4—colon cancer	0.000139	0.0145	CbGpPWpGaD
Folic Acid—ABCG2—vagina—colon cancer	0.000134	0.00684	CbGeAlD
Folic Acid—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	0.000133	0.0139	CbGpPWpGaD
Folic Acid—CYP2E1—lymphoid tissue—colon cancer	0.000133	0.00679	CbGeAlD
Folic Acid—CYP2E1—digestive system—colon cancer	0.000131	0.00671	CbGeAlD
Folic Acid—ABCG2—Irinotecan Pathway—APC—colon cancer	0.000128	0.0133	CbGpPWpGaD
Folic Acid—ABCC3—Fluoropyrimidine Activity—TYMS—colon cancer	0.000127	0.0133	CbGpPWpGaD
Folic Acid—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	0.000127	0.0132	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—CHST5—colon cancer	0.000126	0.0131	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—ODC1—colon cancer	0.000126	0.0131	CbGpPWpGaD
Folic Acid—ABCC4—lymph node—colon cancer	0.000122	0.00627	CbGeAlD
Folic Acid—ABCC3—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000121	0.0126	CbGpPWpGaD
Folic Acid—ABCC4—Fluoropyrimidine Activity—TYMS—colon cancer	0.00012	0.0125	CbGpPWpGaD
Folic Acid—ABCC4—ABC-family proteins mediated transport—ABCB1—colon cancer	0.000114	0.0119	CbGpPWpGaD
Folic Acid—ABCG2—liver—colon cancer	0.000113	0.00577	CbGeAlD
Folic Acid—SLC25A32—Disease—AXIN2—colon cancer	0.000108	0.0113	CbGpPWpGaD
Folic Acid—CYP2E1—liver—colon cancer	9.76e-05	0.005	CbGeAlD
Folic Acid—SLC46A1—Metabolism—CA7—colon cancer	9.55e-05	0.00996	CbGpPWpGaD
Folic Acid—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	8.81e-05	0.00919	CbGpPWpGaD
Folic Acid—ABCG2—Fluoropyrimidine Activity—TYMS—colon cancer	8.78e-05	0.00916	CbGpPWpGaD
Folic Acid—ABCG2—lymph node—colon cancer	8.64e-05	0.00443	CbGeAlD
Folic Acid—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	8.44e-05	0.0088	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—HNF4A—colon cancer	8.23e-05	0.00858	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—LGR5—colon cancer	6.91e-05	0.0072	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—CHST5—colon cancer	6.91e-05	0.0072	CbGpPWpGaD
Folic Acid—MTHFR—Fluoropyrimidine Activity—TP53—colon cancer	6.58e-05	0.00686	CbGpPWpGaD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—colon cancer	6.52e-05	0.0068	CbGpPWpGaD
Folic Acid—CYP2E1—Metapathway biotransformation—CHST5—colon cancer	6.4e-05	0.00667	CbGpPWpGaD
Folic Acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.27e-05	0.00654	CbGpPWpGaD
Folic Acid—SLC46A1—Folate Metabolism—TP53—colon cancer	6.26e-05	0.00653	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—ODC1—colon cancer	5.78e-05	0.00603	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—CHST5—colon cancer	5.78e-05	0.00603	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CA7—colon cancer	5.76e-05	0.00601	CbGpPWpGaD
Folic Acid—Methotrexate—ABCB1—colon cancer	5.31e-05	0.0239	CrCbGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—ABCB1—colon cancer	5.14e-05	0.00536	CbGpPWpGaD
Folic Acid—MTHFR—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—colon cancer	5.09e-05	0.00531	CbGpPWpGaD
Folic Acid—MTHFR—Selenium Micronutrient Network—PTGS2—colon cancer	5.05e-05	0.00526	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—AXIN2—colon cancer	4.96e-05	0.00517	CbGpPWpGaD
Folic Acid—ABCC11—Transmembrane transport of small molecules—ABCB1—colon cancer	4.93e-05	0.00514	CbGpPWpGaD
Folic Acid—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.36e-05	0.00455	CbGpPWpGaD
Folic Acid—ABCC3—Fluoropyrimidine Activity—TP53—colon cancer	4.22e-05	0.00441	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CHST5—colon cancer	4.17e-05	0.00435	CbGpPWpGaD
Folic Acid—MTHFR—Disease—LGR5—colon cancer	4.17e-05	0.00435	CbGpPWpGaD
Folic Acid—ABCG2—HIF-2-alpha transcription factor network—EP300—colon cancer	3.97e-05	0.00414	CbGpPWpGaD
Folic Acid—ABCC4—Fluoropyrimidine Activity—TP53—colon cancer	3.97e-05	0.00414	CbGpPWpGaD
Folic Acid—MTHFR—Folate Metabolism—TP53—colon cancer	3.78e-05	0.00394	CbGpPWpGaD
Folic Acid—ABCG2—HIF-2-alpha transcription factor network—VEGFA—colon cancer	3.76e-05	0.00392	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CA7—colon cancer	3.7e-05	0.00386	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—ODC1—colon cancer	3.49e-05	0.00364	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—CHST5—colon cancer	3.49e-05	0.00364	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—ABCB1—colon cancer	3.33e-05	0.00347	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—TYMS—colon cancer	3.27e-05	0.00341	CbGpPWpGaD
Folic Acid—SLC46A1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.26e-05	0.0034	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—FGFR3—colon cancer	3.12e-05	0.00325	CbGpPWpGaD
Folic Acid—MTHFR—Disease—AXIN2—colon cancer	2.99e-05	0.00312	CbGpPWpGaD
Folic Acid—ABCG2—Fluoropyrimidine Activity—TP53—colon cancer	2.91e-05	0.00304	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—APC—colon cancer	2.87e-05	0.00299	CbGpPWpGaD
Folic Acid—Irritability—Fluorouracil—colon cancer	2.84e-05	0.0288	CcSEcCtD
Folic Acid—Abdominal distension—Irinotecan—colon cancer	2.71e-05	0.0274	CcSEcCtD
Folic Acid—SLC25A32—Disease—BRAF—colon cancer	2.69e-05	0.00281	CbGpPWpGaD
Folic Acid—ABCC4—Platelet degranulation—VEGFA—colon cancer	2.59e-05	0.0027	CbGpPWpGaD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	2.59e-05	0.0027	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CA7—colon cancer	2.55e-05	0.00266	CbGpPWpGaD
Folic Acid—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	2.47e-05	0.00257	CbGpPWpGaD
Folic Acid—Depression—Vincristine—colon cancer	2.45e-05	0.0248	CcSEcCtD
Folic Acid—ABCC4—Platelet degranulation—TGFB1—colon cancer	2.38e-05	0.00248	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—EP300—colon cancer	2.34e-05	0.00244	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PPARG—colon cancer	2.32e-05	0.00242	CbGpPWpGaD
Folic Acid—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	2.26e-05	0.00236	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—ODC1—colon cancer	2.24e-05	0.00234	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—CHST5—colon cancer	2.24e-05	0.00234	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—VEGFA—colon cancer	2.21e-05	0.00231	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—PTGS2—colon cancer	2.18e-05	0.00227	CbGpPWpGaD
Folic Acid—Irritability—Capecitabine—colon cancer	1.99e-05	0.0201	CcSEcCtD
Folic Acid—SLC25A32—Disease—CTNNB1—colon cancer	1.95e-05	0.00203	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—CDKN1A—colon cancer	1.9e-05	0.00198	CbGpPWpGaD
Folic Acid—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	1.9e-05	0.00198	CbGpPWpGaD
Folic Acid—Flatulence—Irinotecan—colon cancer	1.85e-05	0.0187	CcSEcCtD
Folic Acid—CYP2E1—Metabolism—CA7—colon cancer	1.83e-05	0.00191	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PTGS2—colon cancer	1.82e-05	0.0019	CbGpPWpGaD
Folic Acid—Abdominal distension—Capecitabine—colon cancer	1.81e-05	0.0183	CcSEcCtD
Folic Acid—SLC25A32—Disease—EP300—colon cancer	1.81e-05	0.00189	CbGpPWpGaD
Folic Acid—Erythema—Fluorouracil—colon cancer	1.79e-05	0.0181	CcSEcCtD
Folic Acid—Bronchospasm—Capecitabine—colon cancer	1.77e-05	0.0179	CcSEcCtD
Folic Acid—Agitation—Vincristine—colon cancer	1.77e-05	0.0179	CcSEcCtD
Folic Acid—SLC25A32—Disease—SRC—colon cancer	1.76e-05	0.00183	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Irinotecan—colon cancer	1.74e-05	0.0176	CcSEcCtD
Folic Acid—SLC25A32—Disease—NRAS—colon cancer	1.69e-05	0.00177	CbGpPWpGaD
Folic Acid—Malaise—Irinotecan—colon cancer	1.69e-05	0.0171	CcSEcCtD
Folic Acid—Convulsion—Vincristine—colon cancer	1.67e-05	0.0169	CcSEcCtD
Folic Acid—Depression—Capecitabine—colon cancer	1.6e-05	0.0162	CcSEcCtD
Folic Acid—SLC25A32—Disease—MYC—colon cancer	1.58e-05	0.00164	CbGpPWpGaD
Folic Acid—Discomfort—Irinotecan—colon cancer	1.58e-05	0.0159	CcSEcCtD
Folic Acid—SLC25A32—Disease—TGFB1—colon cancer	1.57e-05	0.00164	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Vincristine—colon cancer	1.57e-05	0.0159	CcSEcCtD
Folic Acid—ABCC3—NRF2 pathway—TGFB1—colon cancer	1.56e-05	0.00163	CbGpPWpGaD
Folic Acid—Convulsion—Fluorouracil—colon cancer	1.55e-05	0.0157	CcSEcCtD
Folic Acid—ABCG2—Metabolism—ODC1—colon cancer	1.54e-05	0.00161	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—CHST5—colon cancer	1.54e-05	0.00161	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—EGFR—colon cancer	1.54e-05	0.00161	CbGpPWpGaD
Folic Acid—Confusional state—Irinotecan—colon cancer	1.54e-05	0.0156	CcSEcCtD
Folic Acid—ABCC4—Ectoderm Differentiation—MYC—colon cancer	1.54e-05	0.00161	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Irinotecan—colon cancer	1.53e-05	0.0155	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—ABCB1—colon cancer	1.53e-05	0.00159	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—EP300—colon cancer	1.52e-05	0.00158	CbGpPWpGaD
Folic Acid—Discomfort—Fluorouracil—colon cancer	1.51e-05	0.0153	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—TYMS—colon cancer	1.5e-05	0.00157	CbGpPWpGaD
Folic Acid—Anorexia—Vincristine—colon cancer	1.5e-05	0.0151	CcSEcCtD
Folic Acid—Irritability—Methotrexate—colon cancer	1.48e-05	0.015	CcSEcCtD
Folic Acid—Confusional state—Fluorouracil—colon cancer	1.48e-05	0.0149	CcSEcCtD
Folic Acid—ABCC4—NRF2 pathway—TGFB1—colon cancer	1.47e-05	0.00153	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Fluorouracil—colon cancer	1.46e-05	0.0148	CcSEcCtD
Folic Acid—Anorexia—Irinotecan—colon cancer	1.46e-05	0.0147	CcSEcCtD
Folic Acid—SLC25A32—Disease—KRAS—colon cancer	1.46e-05	0.00152	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—FGFR3—colon cancer	1.43e-05	0.00149	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.41e-05	0.00147	CbGpPWpGaD
Folic Acid—Anorexia—Fluorouracil—colon cancer	1.4e-05	0.0141	CcSEcCtD
Folic Acid—Decreased appetite—Vincristine—colon cancer	1.36e-05	0.0138	CcSEcCtD
Folic Acid—Dyspnoea—Irinotecan—colon cancer	1.36e-05	0.0138	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Vincristine—colon cancer	1.36e-05	0.0137	CcSEcCtD
Folic Acid—Dyspepsia—Irinotecan—colon cancer	1.35e-05	0.0136	CcSEcCtD
Folic Acid—SLC25A32—Disease—PIK3CA—colon cancer	1.34e-05	0.0014	CbGpPWpGaD
Folic Acid—Decreased appetite—Irinotecan—colon cancer	1.33e-05	0.0134	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Irinotecan—colon cancer	1.32e-05	0.0134	CcSEcCtD
Folic Acid—SLC46A1—Disease—APC—colon cancer	1.32e-05	0.00137	CbGpPWpGaD
Folic Acid—Dyspnoea—Fluorouracil—colon cancer	1.31e-05	0.0132	CcSEcCtD
Folic Acid—Dyspepsia—Fluorouracil—colon cancer	1.29e-05	0.013	CcSEcCtD
Folic Acid—Decreased appetite—Fluorouracil—colon cancer	1.27e-05	0.0129	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Fluorouracil—colon cancer	1.26e-05	0.0128	CcSEcCtD
Folic Acid—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.26e-05	0.00132	CbGpPWpGaD
Folic Acid—Feeling abnormal—Irinotecan—colon cancer	1.26e-05	0.0127	CcSEcCtD
Folic Acid—Erythema—Capecitabine—colon cancer	1.25e-05	0.0127	CcSEcCtD
Folic Acid—SLC25A32—Disease—HRAS—colon cancer	1.24e-05	0.00129	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—BRAF—colon cancer	1.24e-05	0.00129	CbGpPWpGaD
Folic Acid—Flatulence—Capecitabine—colon cancer	1.24e-05	0.0125	CcSEcCtD
Folic Acid—Dysgeusia—Capecitabine—colon cancer	1.23e-05	0.0124	CcSEcCtD
Folic Acid—Feeling abnormal—Fluorouracil—colon cancer	1.21e-05	0.0122	CcSEcCtD
Folic Acid—Depression—Methotrexate—colon cancer	1.19e-05	0.012	CcSEcCtD
Folic Acid—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	1.19e-05	0.00124	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	1.18e-05	0.00123	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Capecitabine—colon cancer	1.16e-05	0.0118	CcSEcCtD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	1.15e-05	0.0012	CbGpPWpGaD
Folic Acid—Malaise—Capecitabine—colon cancer	1.13e-05	0.0114	CcSEcCtD
Folic Acid—SLC25A32—Metabolism—PIK3CA—colon cancer	1.12e-05	0.00117	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ODC1—colon cancer	1.11e-05	0.00116	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—CHST5—colon cancer	1.11e-05	0.00116	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—AKT1—colon cancer	1.09e-05	0.00114	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PPARG—colon cancer	1.06e-05	0.00111	CbGpPWpGaD
Folic Acid—Discomfort—Capecitabine—colon cancer	1.05e-05	0.0107	CcSEcCtD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	1.05e-05	0.0011	CbGpPWpGaD
Folic Acid—Pruritus—Fluorouracil—colon cancer	1.04e-05	0.0105	CcSEcCtD
Folic Acid—SLC22A6—Transmembrane transport of small molecules—ABCB1—colon cancer	1.03e-05	0.00108	CbGpPWpGaD
Folic Acid—Confusional state—Capecitabine—colon cancer	1.03e-05	0.0104	CcSEcCtD
Folic Acid—SLC46A1—Disease—PTGS2—colon cancer	9.99e-06	0.00104	CbGpPWpGaD
Folic Acid—Rash—Vincristine—colon cancer	9.9e-06	0.01	CcSEcCtD
Folic Acid—Dermatitis—Vincristine—colon cancer	9.89e-06	0.01	CcSEcCtD
Folic Acid—Anorexia—Capecitabine—colon cancer	9.75e-06	0.00987	CcSEcCtD
Folic Acid—Rash—Irinotecan—colon cancer	9.64e-06	0.00975	CcSEcCtD
Folic Acid—Dermatitis—Irinotecan—colon cancer	9.63e-06	0.00974	CcSEcCtD
Folic Acid—Erythema—Methotrexate—colon cancer	9.33e-06	0.00944	CcSEcCtD
Folic Acid—Nausea—Vincristine—colon cancer	9.32e-06	0.00943	CcSEcCtD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	9.25e-06	0.000964	CbGpPWpGaD
Folic Acid—Rash—Fluorouracil—colon cancer	9.23e-06	0.00934	CcSEcCtD
Folic Acid—MTHFR—Metabolism—ABCB1—colon cancer	9.22e-06	0.000962	CbGpPWpGaD
Folic Acid—Dermatitis—Fluorouracil—colon cancer	9.22e-06	0.00933	CcSEcCtD
Folic Acid—SLC25A32—Metabolism—AKT1—colon cancer	9.16e-06	0.000955	CbGpPWpGaD
Folic Acid—Dysgeusia—Methotrexate—colon cancer	9.14e-06	0.00925	CcSEcCtD
Folic Acid—Dyspnoea—Capecitabine—colon cancer	9.12e-06	0.00923	CcSEcCtD
Folic Acid—Nausea—Irinotecan—colon cancer	9.08e-06	0.00919	CcSEcCtD
Folic Acid—MTHFR—Metabolism—TYMS—colon cancer	9.06e-06	0.000945	CbGpPWpGaD
Folic Acid—Dyspepsia—Capecitabine—colon cancer	9.01e-06	0.00911	CcSEcCtD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	8.97e-06	0.000935	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—CTNNB1—colon cancer	8.94e-06	0.000932	CbGpPWpGaD
Folic Acid—Decreased appetite—Capecitabine—colon cancer	8.89e-06	0.009	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Capecitabine—colon cancer	8.83e-06	0.00894	CcSEcCtD
Folic Acid—SLC46A1—Disease—CDKN1A—colon cancer	8.73e-06	0.000911	CbGpPWpGaD
Folic Acid—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	8.71e-06	0.000909	CbGpPWpGaD
Folic Acid—Nausea—Fluorouracil—colon cancer	8.7e-06	0.0088	CcSEcCtD
Folic Acid—Ill-defined disorder—Methotrexate—colon cancer	8.66e-06	0.00876	CcSEcCtD
Folic Acid—MTHFR—Disease—FGFR3—colon cancer	8.65e-06	0.000902	CbGpPWpGaD
Folic Acid—Feeling abnormal—Capecitabine—colon cancer	8.43e-06	0.00853	CcSEcCtD
Folic Acid—Malaise—Methotrexate—colon cancer	8.42e-06	0.00851	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—PTGS2—colon cancer	8.37e-06	0.000872	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EP300—colon cancer	8.31e-06	0.000866	CbGpPWpGaD
Folic Acid—Convulsion—Methotrexate—colon cancer	8.09e-06	0.00818	CcSEcCtD
Folic Acid—SLC46A1—Disease—SRC—colon cancer	8.08e-06	0.000842	CbGpPWpGaD
Folic Acid—MTHFR—Disease—APC—colon cancer	7.94e-06	0.000828	CbGpPWpGaD
Folic Acid—Discomfort—Methotrexate—colon cancer	7.85e-06	0.00794	CcSEcCtD
Folic Acid—SLC46A1—Disease—NRAS—colon cancer	7.77e-06	0.000811	CbGpPWpGaD
Folic Acid—Confusional state—Methotrexate—colon cancer	7.68e-06	0.00777	CcSEcCtD
Folic Acid—Anaphylactic shock—Methotrexate—colon cancer	7.62e-06	0.00771	CcSEcCtD
Folic Acid—MTHFR—Disease—BRAF—colon cancer	7.46e-06	0.000778	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	7.33e-06	0.000764	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	7.27e-06	0.000759	CbGpPWpGaD
Folic Acid—Anorexia—Methotrexate—colon cancer	7.26e-06	0.00735	CcSEcCtD
Folic Acid—SLC46A1—Disease—MYC—colon cancer	7.24e-06	0.000755	CbGpPWpGaD
Folic Acid—Pruritus—Capecitabine—colon cancer	7.24e-06	0.00732	CcSEcCtD
Folic Acid—SLC46A1—Disease—TGFB1—colon cancer	7.22e-06	0.000753	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EGFR—colon cancer	7.08e-06	0.000738	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—EP300—colon cancer	6.96e-06	0.000726	CbGpPWpGaD
Folic Acid—Dyspnoea—Methotrexate—colon cancer	6.79e-06	0.00687	CcSEcCtD
Folic Acid—Dyspepsia—Methotrexate—colon cancer	6.7e-06	0.00678	CcSEcCtD
Folic Acid—SLC46A1—Disease—KRAS—colon cancer	6.69e-06	0.000698	CbGpPWpGaD
Folic Acid—Decreased appetite—Methotrexate—colon cancer	6.62e-06	0.0067	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Methotrexate—colon cancer	6.58e-06	0.00665	CcSEcCtD
Folic Acid—Rash—Capecitabine—colon cancer	6.45e-06	0.00653	CcSEcCtD
Folic Acid—Dermatitis—Capecitabine—colon cancer	6.45e-06	0.00652	CcSEcCtD
Folic Acid—MTHFR—Metabolism—PPARG—colon cancer	6.42e-06	0.000669	CbGpPWpGaD
Folic Acid—Feeling abnormal—Methotrexate—colon cancer	6.28e-06	0.00635	CcSEcCtD
Folic Acid—ABCC4—Hemostasis—EP300—colon cancer	6.25e-06	0.000652	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—PIK3CA—colon cancer	6.15e-06	0.000641	CbGpPWpGaD
Folic Acid—Nausea—Capecitabine—colon cancer	6.08e-06	0.00615	CcSEcCtD
Folic Acid—ABCC4—Hemostasis—SRC—colon cancer	6.08e-06	0.000634	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.05e-06	0.000631	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PTGS2—colon cancer	6.03e-06	0.000629	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—ABCB1—colon cancer	5.92e-06	0.000617	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—VEGFA—colon cancer	5.92e-06	0.000617	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—NRAS—colon cancer	5.85e-06	0.00061	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—TYMS—colon cancer	5.81e-06	0.000606	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—HRAS—colon cancer	5.69e-06	0.000593	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TGFB1—colon cancer	5.43e-06	0.000566	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CTNNB1—colon cancer	5.39e-06	0.000562	CbGpPWpGaD
Folic Acid—Pruritus—Methotrexate—colon cancer	5.39e-06	0.00545	CcSEcCtD
Folic Acid—MTHFR—Disease—CDKN1A—colon cancer	5.27e-06	0.000549	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—PIK3CA—colon cancer	5.15e-06	0.000537	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PTGS2—colon cancer	5.05e-06	0.000526	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—KRAS—colon cancer	5.03e-06	0.000525	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—AKT1—colon cancer	5.02e-06	0.000524	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EP300—colon cancer	5.01e-06	0.000523	CbGpPWpGaD
Folic Acid—MTHFR—Disease—SRC—colon cancer	4.87e-06	0.000508	CbGpPWpGaD
Folic Acid—Rash—Methotrexate—colon cancer	4.8e-06	0.00486	CcSEcCtD
Folic Acid—Dermatitis—Methotrexate—colon cancer	4.8e-06	0.00485	CcSEcCtD
Folic Acid—MTHFR—Disease—NRAS—colon cancer	4.69e-06	0.000489	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—PIK3CA—colon cancer	4.62e-06	0.000482	CbGpPWpGaD
Folic Acid—Nausea—Methotrexate—colon cancer	4.52e-06	0.00458	CcSEcCtD
Folic Acid—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.48e-06	0.000467	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TP53—colon cancer	4.47e-06	0.000466	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MYC—colon cancer	4.37e-06	0.000456	CbGpPWpGaD
Folic Acid—MTHFR—Disease—TGFB1—colon cancer	4.36e-06	0.000454	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—HRAS—colon cancer	4.28e-06	0.000446	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EGFR—colon cancer	4.27e-06	0.000446	CbGpPWpGaD
Folic Acid—SLC46A1—Metabolism—AKT1—colon cancer	4.2e-06	0.000438	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—EP300—colon cancer	4.2e-06	0.000438	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PPARG—colon cancer	4.12e-06	0.000429	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ABCB1—colon cancer	4.08e-06	0.000426	CbGpPWpGaD
Folic Acid—MTHFR—Disease—KRAS—colon cancer	4.04e-06	0.000421	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—TYMS—colon cancer	4.01e-06	0.000418	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—AKT1—colon cancer	3.78e-06	0.000394	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PIK3CA—colon cancer	3.71e-06	0.000387	CbGpPWpGaD
Folic Acid—MTHFR—Disease—HRAS—colon cancer	3.43e-06	0.000358	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PTGS2—colon cancer	3.24e-06	0.000338	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—PIK3CA—colon cancer	3.11e-06	0.000324	CbGpPWpGaD
Folic Acid—MTHFR—Disease—AKT1—colon cancer	3.03e-06	0.000316	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ABCB1—colon cancer	2.93e-06	0.000306	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—TYMS—colon cancer	2.88e-06	0.0003	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PPARG—colon cancer	2.84e-06	0.000296	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—EP300—colon cancer	2.69e-06	0.000281	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—AKT1—colon cancer	2.54e-06	0.000265	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PTGS2—colon cancer	2.23e-06	0.000233	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PPARG—colon cancer	2.04e-06	0.000213	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PIK3CA—colon cancer	1.99e-06	0.000208	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—EP300—colon cancer	1.86e-06	0.000194	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—AKT1—colon cancer	1.63e-06	0.00017	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PTGS2—colon cancer	1.6e-06	0.000167	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PIK3CA—colon cancer	1.37e-06	0.000143	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—EP300—colon cancer	1.33e-06	0.000139	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—AKT1—colon cancer	1.12e-06	0.000117	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PIK3CA—colon cancer	9.87e-07	0.000103	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—AKT1—colon cancer	8.06e-07	8.41e-05	CbGpPWpGaD
